Spex Capital is an Esher, United Kingdom-based venture capital firm investing globally in early-stage digital healthcare and med-tech companies. It targets businesses using digital technologies with traction across HealthTech, medical devices, biotechnology, diagnostics, life sciences, AI/data and cloud-enabled healthcare. The firm typically invests €500k-€2m at seed or first ticket, up to €5m at Series A, and provides follow-on capital at Series B in select cases, with healthcare-sector expertise and partner networks supporting due diligence and scaling.